论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
列线图预测 ST 段抬高型心肌梗死和多支冠状动脉疾病分期血运重建后的结果
Received 29 December 2023
Accepted for publication 20 April 2024
Published 29 April 2024 Volume 2024:17 Pages 1713—1722
DOI https://doi.org/10.2147/IJGM.S457236
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Redoy Ranjan
Huaigen Wang,1 Aiqun Ma,1,2 Tingzhong Wang1,2
1Department of Cardiovascular Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, People’s Republic of China; 2Shaanxi Key Laboratory of Molecular Cardiology (Xi’an Jiaotong University), Xi’an, Shaanxi, People’s Republic of China
Correspondence: Aiqun Ma; Tingzhong Wang, Email aiqun.ma@xjtu.edu.cn; tingzhong.wang@xjtu.edu.cn
Objective: Approximately 50% of ST-segment elevation myocardial infarction (STEMI) patients have multivessel coronary artery disease (MVD). The management strategy for these patients remains controversial. This study aimed to develop predictive models and nomogram of outcomes in STEMI patients with MVD for better identification and classification.
Methods: The least absolute shrinkage and selection operator (LASSO) method was used to select the features most significantly associated with the outcomes. A Cox regression model was built using the selected variables. One nomogram was computed from each model, and individual risk scores were obtained by applying the nomograms to the cohort. After regrouping patients based on nomogram risk scores into low- and high-risk groups, we used the Kaplan–Meier method to perform survival analysis.
Results: The C-index of the major adverse cardiovascular event (MACE)-free survival model was 0· 68 (95% CI 0· 62– 0· 74) and 0· 65 [0· 62– 0· 68]) at internal validation, and that of the overall survival model was 0· 75 (95% CI 0· 66– 0· 84) and (0· 73 [0· 65– 0· 81]). The predictions of both models correlated with the observed outcomes. Low-risk patients had significantly lower probabilities of 1-year or 3-year MACEs (4% versus 11%, P= 0.003; 7% versus 15%, P=0.01, respectively) and 1-year or 3-year all-cause death (1% versus 3%, P=0.048; 2% versus 7%, respectively, P=0.001) than high-risk patients.
Conclusion: Our nomograms can be used to predict STEMI and MVD outcomes in a simple and practical way for patients who undergo primary PCI for culprit vessels and staged PCI for non-culprit vessels.
Keywords: ST-segment elevation myocardial infarction, multivessel coronary artery disease, percutaneous coronary intervention, major adverse cardiovascular events, all-cause death